Biomarkers for Oncology
JH · Effective Oct 1, 2015
20 active Medicare policies list N40.2, and 1 commercial payer policy lists it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Jul 17, 2022
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
1 policy from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of N40.2 |
|---|---|---|
| Benign Prostatic Hyperplasia | Feb 8, 2024 | Covered |
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2026
National · Effective Jun 25, 2026
National · Effective Jun 25, 2026
National · Effective Jun 25, 2026
J5 · Effective Jun 25, 2026
J6 · Effective Apr 1, 2026